This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Kiromic BioPharma Beheer
Beheer criteriumcontroles 0/4
Kiromic BioPharma's CEO is Pietro Bersani, appointed in Jan 2022, has a tenure of 1.42 years. total yearly compensation is $697.49K, comprised of 71.2% salary and 28.8% bonuses, including company stock and options. directly owns 2.19% of the company’s shares, worth €60.70K. The average tenure of the management team and the board of directors is 0.9 years and 2.7 years respectively.
Belangrijke informatie
Pietro Bersani
Algemeen directeur
US$697.5k
Totale compensatie
Percentage CEO-salaris | 71.2% |
Dienstverband CEO | 1.4yrs |
Eigendom CEO | 2.2% |
Management gemiddelde ambtstermijn | less than a year |
Gemiddelde ambtstermijn bestuur | 2.7yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$33m |
Dec 31 2022 | US$697k | US$497k | -US$35m |
Sep 30 2022 | n/a | n/a | -US$39m |
Jun 30 2022 | n/a | n/a | -US$33m |
Mar 31 2022 | n/a | n/a | -US$29m |
Dec 31 2021 | US$336k | US$168k | -US$26m |
Sep 30 2021 | n/a | n/a | -US$19m |
Jun 30 2021 | n/a | n/a | -US$15m |
Mar 31 2021 | n/a | n/a | -US$22m |
Dec 31 2020 | US$63k | n/a | -US$20m |
Compensatie versus markt: Pietro's total compensation ($USD697.49K) is above average for companies of similar size in the German market ($USD418.12K).
Compensatie versus inkomsten: Pietro's compensation has increased whilst the company is unprofitable.
CEO
Pietro Bersani (55 yo)
1.4yrs
Tenure
US$697,486
Compensatie
Mr. Pietro Bersani, CPA, J.D., serves as Chief Executive Officer at Kiromic BioPharma, Inc. since May 10, 2022 and serves as Director since January 27, 2022. He serves as Principal Financial Officer at Kir...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, Principal Financial Officer & Director | 1.4yrs | US$697.49k | 2.19% € 60.7k | |
Chief Financial Officer | less than a year | geen gegevens | geen gegevens | |
CSO & Interim COO | less than a year | geen gegevens | 0.013% € 373.5 | |
Chief of Staff | 3.7yrs | US$442.12k | 0% € 0 | |
Controller | less than a year | geen gegevens | geen gegevens |
0.9yrs
Gemiddelde duur
Ervaren management: 5JU0's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO, Principal Financial Officer & Director | 3yrs | US$697.49k | 2.19% € 60.7k | |
Independent Chairperson of the Board | 2.7yrs | US$214.20k | 0.64% € 17.8k | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Independent Director | 3.3yrs | US$187.96k | 0.64% € 17.8k | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | no data | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 2.4yrs | geen gegevens | geen gegevens | |
Member of Scientific Advisory Board | 1.8yrs | geen gegevens | geen gegevens |
2.7yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren bestuur: 5JU0's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.